### What should I do if I experience a low blood-sugar episode while taking Micronase? If you feel symptoms of hypoglycaemia (e.g., shakiness, sweating, rapid heartbeat), consume 15 g of fast-acting carbohydrate such as glucose tablets, fruit juice, or regular (non-diet) soda. Re-check your blood glucose after 15 minutes and repeat if needed. If you are unable to treat yourself, seek emergency assistance.
### Can Micronase be taken with other diabetes tablets? Yes, it is often combined with metformin or a DPP-4 inhibitor when monotherapy does not achieve target glucose levels. Dose adjustments are required to avoid excessive hypoglycaemia, so any combination should be prescribed and monitored by your clinician.
### Does Micronase affect my ability to drive or operate machinery? Hypoglycaemia can impair concentration and reaction time. Until you know how Micronase influences your blood glucose, avoid driving or hazardous tasks when you have not eaten for several hours or if you feel any warning signs of low sugar.
### How does Micronase compare with newer drugs like SGLT2 inhibitors? Both classes lower blood glucose, but their mechanisms differ: sulfonylureas increase insulin secretion, whereas SGLT2 inhibitors promote urinary glucose excretion. SGLT2 inhibitors have additional benefits such as weight loss and cardiovascular protection, but they may be more expensive and have distinct side-effect profiles. Choice of therapy depends on individual medical history, cost considerations, and clinician judgment.
### Is it safe to consume alcohol while on Micronase? Alcohol can amplify the insulin-releasing effect of glibenclamide and increase the risk of hypoglycaemia, especially if you drink without eating. If you choose to drink, do so in moderation, have food with each alcoholic drink, and monitor your blood glucose closely.
### Why does Micronase sometimes cause weight gain? By increasing insulin levels, the drug can promote the storage of glucose as fat, leading to modest weight gain. Lifestyle measures-balanced diet and regular physical activity-remain essential to mitigate this effect.
### I travel internationally; do I need to declare Micronase at customs? In the UK, Micronase is a prescription-only medication. When travelling, carry the original prescription label or a doctor’s letter confirming its medical necessity. Declare the medication if required by the destination country’s customs regulations.
### Are there any visual differences between the 2.5 mg and 5 mg tablets? Both strengths are round, film-coated tablets but differ in colour and imprint. The 2.5 mg tablet typically bears a lighter shade and a specific alphanumeric code, while the 5 mg tablet is darker with a distinct imprint. Refer to the pharmacy’s dispensing label for exact identification.
### How long can I keep unused Micronase tablets after opening the bottle? When stored as instructed (room temperature, dry environment, bottle tightly closed), the tablets remain stable until the printed expiry date. Do not use tablets that appear discoloured, crumbling, or have an unusual odor.
### What factors influence the dose adjustment of Micronase? Dose titration depends on fasting and post-prandial blood-glucose readings, HbA1c results, presence of renal or hepatic impairment, and concurrent hypoglycaemic agents. Your prescriber will review these parameters regularly to determine the safest and most effective dose.
Micronase is a brand-name medication that contains the active ingredient glibenclamide (also known as glyburide). It belongs to the sulfonylurea class of oral anti-diabetic drugs. Micronase is supplied as a tablet (pill) in two strengths - 2.5 mg and 5 mg. In the United Kingdom it is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Glibenclamide stimulates the pancreas to release more insulin. It binds to the sulfonylurea receptor on pancreatic β-cells, closing ATP-sensitive potassium channels. This depolarises the cell membrane, opens calcium channels, and triggers insulin secretion.
Because the drug relies on functional β-cells, it is effective only in people with type 2 diabetes who still produce insulin.
Micronase is licensed in the UK for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise. It may be used alone or in combination with other glucose-lowering agents such as metformin or thiazolidinediones when monotherapy does not achieve glycaemic targets.
Typical patients are adults with inadequate glycaemic control who have preserved pancreatic β-cell function.
Disclaimer: Off-label use must be supervised by a qualified healthcare professional and involves individualized risk assessment.
Ideal candidates
Absolute contraindications
Relative contraindications
Major:
CYP2C9 inhibitors (e.g., fluconazole, amiodarone) can raise glibenclamide levels, increasing hypoglycaemia risk.
Other hypoglycaemic agents (insulin, metformin, GLP-1 agonists) - additive glucose-lowering effect, requiring dose adjustments.
Moderate:
Non-steroidal anti-inflammatory drugs (NSAIDs) may potentiate hypoglycaemia.
Beta-blockers can mask hypoglycaemia symptoms.
Food and Lifestyle:
Alcohol enhances insulin release and may precipitate hypoglycaemia.
High-fat meals can delay absorption, slightly altering peak effect.
Safety tip: Always provide your prescriber with a complete list of prescription medicines, over-the-counter drugs, herbal supplements, and dietary habits before starting Micronase.
Standard dosing:
Initial dose: 2.5 mg taken once daily with the first main meal (usually breakfast).
Dose titration: If glycaemic control is inadequate after 2-4 weeks, the prescriber may increase the dose to 5 mg once daily. The total daily dose should not exceed 5 mg for most patients, given the available tablet strengths.
Special populations:
Renal impairment: Start with 2.5 mg; consider extending dosing interval (e.g., every other day) under medical supervision.
Elderly: Use the lowest effective dose and monitor closely for hypoglycaemia.
Administration: Swallow tablets whole with a glass of water. Do not crush, chew, or split the tablet unless specifically instructed.
Missed dose: If you remember within 12 hours, take the tablet with the next main meal. If more than 12 hours have passed, skip the missed dose and resume the regular schedule. Do not double the dose.
Overdose: Symptoms may include profound hypoglycaemia, dizziness, or loss of consciousness. Seek emergency medical attention immediately; treatment typically involves rapid administration of glucose (oral or intravenous).
Discontinuation: Abrupt cessation is not usually required, but dose reduction may be advisable if switching to another therapy to avoid rebound hyperglycaemia.
This article provides educational information about Micronase (glibenclamide) and is not a substitute for professional medical advice. Treatment decisions, including the use of any medication for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
